Focuses genomic and proteomic lenses on three canine cancers
Continue reading
Category Archives: AZBio News
C-Path Announces Jennifer Kendra as New Vice President of Strategic Relationships
New Leadership to Drive Expansion of Collaborative Initiatives and Fundraising Strategies at C-PathContinue reading
U of A Cancer Center clinical trial advances research in treatment of biliary tract cancers
Experimental, three-drug chemotherapy regimen didn’t improve survival rates for patients, but treatment might still prove helpful for a small subset of patients.Continue reading
GT Medical Technologies Raises $37 Million in Series D to Advance the Expansion of GammaTile® in the U.S. for Patients with Operable Brain Tumors
Financing Led by Evidity Health Capital Continue reading
Applications open for XLR8 Health Tech Program
XLR8 PBC is an 8-day intensive program for scale-ready (series A/B) companies seeking the capital, experience, and industry validation to move to the next level. The program emphasizes finding the right capital at the right time, growth-stage executive matchmaking, and corporate partnerships to validate market fit. With resources like access to innovative collision spaces, student analysts, and a robust ecosystem, XLR8 is dedicated to enhancing the growth potential of scale-ups.Continue reading
NIH Recognizes the Syn-One Test® as a Top Medical Finding for 2024
The National Institutes of Health (NIH) has recognized the Syn-One Test as one of its “Top Promising Medical Findings for 2024”. The skin-biopsy test is the first commercially available test of its kind that can detect phosphorylated alpha-synuclein (P-SYN), a protein indicative of Parkinson’s disease (PD) and related synucleinopathies, including dementia with Lewy bodies (DLB), multiple system atrophy (MSA), and pure autonomic failure (PAF).Continue reading
C-Path’s TRxA Announces 2025 Request for Proposals from Academic Investigators
New Funding Opportunity for Drug Development ProjectsContinue reading
Ten Arizona research teams earn $100K Flinn Foundation seed grants
The Flinn Foundation Seed Grants to Promote Translational Research program has awarded a combined $1 million to 10 Arizona research teams with the potential to turn their findings into viable products and treatments that impact patients. The program’s 10th cohort was selected in an open competitive process among 82 proposals from 13 universities, health systems, and research institutes — an increase from last year’s 73 applications.Continue reading
Arizonans Hit the Streets of San Francisco for JPM Week
Each year JPM Week brings together health innovators and investors to refresh or make the connections that drive health Invaton Forward Faster. See where thy are in the spotlight this week.Continue reading